Pulmonx, Corp.

Pulmonx, Corp. is a respiratory-device company with a very specific lane: minimally invasive treatment for severe emphysema, especially through its endobronchial valve system. By our assessment, that specificity is its strength, because it targets a narrow group of patients with a real clinical need rather than trying to be all things to pulmonology. The downside is that such a focused product line leaves little room for casual appeal and depends heavily on specialist care and patient selection. In practice, this is not consumer health; it is a specialist tool used inside a careful medical workflow. Pulmonx, Corp. sits apart from broad respiratory suppliers because it is built around one flagship approach, not a whole shelf of general devices. The limit is simple: if that clinical use case is not the one in front of you, the company’s value is much less visible.